Hi everyone, I’m in the process of migrating this blog to a new host server called wpengine. As a result, during this process it is possible that the website may look funny, be missing certain elements, or be down over the next few days. Thanks for your patience. Paul
Heads up to readers: www.ipscell.com host migration Read More »
I recently had a phone interview with Dr. Arnold Caplan, the founder of the MSC field. You can read parts 1 and 2 of the interview here and here. Today’s post, part 3, is focused on clinical use of MSCs. I want to start off today’s post with a wonderful quote from Caplan: “All MSCs
I have a new resource page up on the blog that includes links to most of the important stem cell legal decisions and the documents involved. You might call it a stem cell lawyer’s Nirvana page, but I think educators, doctors, scientists, patients, and others will also find it quite useful. If you know of
Lawyer’s guide to stem cells Read More »
The Asahi Shimbun just published a fun, intriguing interview with Shinya Yamanaka, the Nobel Laureate who first produce iPS cells. In the interview, Yamanaka says that the celebrity aspect of his new post-Nobel life has driven him to wear disguises when out running in public because he gets recognized so often. Yamanaka is also asked
Great new Yamanaka interview on iPS cell safety, being a celebrity, & future plans Read More »
CIRM recently held an “elevator pitch” (also sometimes known as an “elevator speech”) contest amongst its grantees. The San Francisco Chronicle even covered this contest (and also here). Kevin McCormack, Sr. Director of Public Communications and Patient Advocate Outreach at CIRM, described the contest in, appropriately enough, a speech. As best as I can tell 56 scientists participated. By way
My top 3 favorite CIRM elevator pitches Read More »
It may come as an annoyance or surprise to some folks in the non-compliant stem cell clinic world that there are laws, rules, and licensing involved in giving stem cell transplants to patients. (To be clear here, this post is focused on clinics transplanting propagated stem cell drug therapies that the FDA views as more
You want sauerkraut on those stem cells? Defining the term “unlicensed” stem cell clinic Read More »
Five legends and a blogger walk into a bar together. The bartender asks the first legend “What can I get for you?” The legend orders their drink. The bartender eventually serves up drinks to all five legends and turns to the blogger, “And what can I get for you?” The blogger replies, “Do you have Wi-Fi?
CIRM has indicated that the Institute of Medicine (IOM) recommended that CIRM provide funding for training and research on ethics and regulatory issues. In response to this recommendation and with the perspectives of various “CIRM funded researchers and other experts”, CIRM has responded with a new ethics & regulatory recommendation document. I have read it
CIRM Ethics & Regulatory Steps: highly responsive to IOM Read More »
It has been a tough year for Korean stem cell biotech RNL Bio in my opinion. It is involved in litigation with former patients and its former partner, Celltex. It is also reportedly under investigation by the Korean Government for alleged stem cell smuggling. The stock of this publicly-traded company has also been battered. On
Tough times at stem cell company RNL Bio Read More »
Would you want a GI specialist doing your heart surgery? How about a radiologist doing your brain surgery? I wouldn’t. So why then do so many patients accept that the doctor doing their stem cell transplant has no training in that area? I’m doing a series on eight simple reasons not to get an unlicensed